Srinivas Akkaraju, Director at Syros Pharmaceuticals, Inc. (SYRS), bought 1,809,954 shares at $4.42 ($8.0M) on 2023-12-21, disclosed to the SEC on 2023-12-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.42 | 904,977 | $4.0M | 50.0% |
| 2 | $4.42 | 904,977 | $4.0M | 50.0% |
| Total | $4.42 avg | 1,809,954 | $8.0M | 100% |
| Filing → |
| KLRS | BUY | 2026-05-22 | $1.2M | — | Filing → |
| ALMS | BUY | 2026-01-13 | $10.0M | — | Filing → |
| SRRK | BUY | 2025-12-16 | $1.9M | — | Filing → |